IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lion Point Capital, LP

Q4 2024 Holdings

Filed 2025-02-14 | 19 holdings | $19.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Insmed Inc(INSM)COM PAR $.01457669307$2.5M36,70013.3%
Milestone Pharmaceuticals in(MIST)COM59935V107$2.4M1,025,80612.7%
Geron Corp(GERN)COM374163103$1.8M500,0009.3%
Ardelyx Inc(ARDX)COM039697107$1.7M335,4008.9%
Fennec Pharmaceuticals Inc(FENC)COM31447P100$1.2M195,7006.5%
Bridgebio Pharma Inc(BBIO)COM10806X102$1.1M40,3005.8%
Mineralys Therapeutics Inc(MLYS)COM603170101$972.5K79,0005.1%
Kiniksa Pharmaceuticals LTD(KNSA)ORD SHS CL AG52694109$907.9K45,9004.8%
Biohaven LTD(BHVN)COMG1110E107$847.8K22,7004.4%
Benitec Biopharma Inc(BNTC)COM NEW08205P209$783.1K62,0004.1%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$727.1K55,0003.8%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$684.2K32,0003.6%
Avadel Pharmaceuticals PLCCOM SHSG29687103$672.6K64,0003.5%
Disc Medicine Inc(IRON)COM254604101$672.0K10,6003.5%
Bluebird BIO Inc(BLE0)COM NEW09609G209$658.1K78,9123.4%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$645.0K46,3003.4%
Regenxbio Inc(RGNX)COM75901B107$446.4K57,7502.3%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$283.2K340,7611.5%
Spruce Biosciences IncCOM85209E109$31.5K75,0000.2%